Log in | Register

Effects of levosimendan for perioperative cardiovascular dysfunction in patients receiving cardiac surgery: a meta-analysis with trial sequential analysis

Chen-Tse Lee| Yu-Cih Lin| Yu-Chang Yeh| Ta-Liang Chen| Chien-Yu Chen
Letter
Volume 43, Issue 12 / December , 2017

Pages 1929 - 1930

No abstract available.

References

  1. Harrison RW, Hasselblad V, Mehta RH et al (2013) Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 27:1224–1232. doi:10.1053/j.jvca.2013.03.027
    • View reference on publisher's website
    • View reference on PubMed
  2. Lim JY, Deo SV, Rababa’h A et al (2015) Levosimendan reduces mortality in adults with left ventricular dysfunction undergoing cardiac surgery: a systematic review and meta-analysis. J Card Surg 30:547–554. doi:10.1111/jocs.12562
    • View reference on publisher's website
    • View reference on PubMed
  3. Koster G, Wetterslev J, Gluud C et al (2015) Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41:203–221. doi:10.1007/s00134-014-3604-1
  4. Landoni G, Lomivorotov VV, Alvaro G et al (2017) Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med 376:2021–2031. doi:10.1056/NEJMoa1616325
    • View reference on publisher's website
    • View reference on PubMed
  5. Mehta RH, Leimberger JD, van Diepen S et al (2017) Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med 376:2032–2042. doi:10.1056/NEJMoa1616218
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement